The Quinolones by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Quinolones Market:
https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report
According to The Business Research Company’s Quinolones, The quinolones market size has grown steadily in recent years. It will grow from $48.31 billion in 2023 to $50.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to antibiotic demand and usage, regulatory approvals, research and development, competitive landscape, patent expirations.
The quinolones market size is expected to see steady growth in the next few years. It will grow to $61.51 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to emerging diseases, regulatory changes, global health policies:, rising antibiotic resistance, market expansion strategies. Major trends in the forecast period include .
The rise in the incidence of infectious diseases is significantly contributing to the growth of the quinolones market. Infectious diseases refer to illnesses brought on by microbes such as parasites, fungi, bacteria, and viruses. Quinolones are widely used for treating a variety of infectious diseases caused by bacteria such as tuberculosis and urinary tract infections. For instance, according to 2022 data released by the Pan American Health Organization, a US-based international public health agency working to improve the health and living standards of the people of the Americas, approximately 10.6 million people fell ill with tuberculosis (TB) in 2021, an increase of 4.5%. Therefore, the rise in the incidence of infectious diseases will drive the quinolones market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp
The quinolones market covered in this report is segmented –
1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Product innovation is the key trend gaining popularity in the quinolones market. Major companies operating in the quinolones market are focusing on developing innovative products to sustain their market position. For instance, in January 2023, the South Korean branch of Viatris, a US-based pharmaceutical company launched Dovprela, a new drug-resistant tuberculosis treatment. Dovprela is a three-drug regimen of bedaquiline, pretomanid, and linezolid (BPaL) for treating adult patients with extensively drug-resistant TB and treatment-resistant or non-responsive multidrug-resistant TB. Dovprela reduces the treatment period from 18-20 months to 5-6 months due to its rapid anti-tuberculosis effect.
The quinolones market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
